[1]邵毅.血清滴眼液治疗严重眼表疾病:英国皇家科学院临床规范指南解读[J].眼科新进展,2020,40(2):101-104.[doi:10.13389/j.cnki.rao.2020.0025]
 SHAO Yi.Interpretation of guidelines for clinical standards of RCO serum eye drops in treatment of severe ocular surface diseases[J].Recent Advances in Ophthalmology,2020,40(2):101-104.[doi:10.13389/j.cnki.rao.2020.0025]
点击复制

血清滴眼液治疗严重眼表疾病:英国皇家科学院临床规范指南解读/HTML
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
40卷
期数:
2020年2期
页码:
101-104
栏目:
述评
出版日期:
2020-02-05

文章信息/Info

Title:
Interpretation of guidelines for clinical standards of RCO serum eye drops in treatment of severe ocular surface diseases
作者:
邵毅
330006 江西省南昌市,南昌大学第一附属医院眼科
Author(s):
SHAO Yi
Department of Ophthalmology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,Jiangxi Province,China
关键词:
眼表疾病血清滴眼液临床规范
Keywords:
ocular surface diseaseserum eye dropsclinical standard
分类号:
R772.2
DOI:
10.13389/j.cnki.rao.2020.0025
文献标志码:
A
摘要:
英国皇家眼科学院近期出台的血清滴眼液治疗严重眼表疾病临床指南,对血清滴眼液治疗严重眼表疾病的现状、机制、适用人群与推荐标准等做了详细介绍。本文将对该指南进行全面解读。
Abstract:
The Royal College of Ophthalmologists recently issues clinical guidelines on serum eye drops for the treatment of serious ocular surface diseases,which gives a detailed introduction to the current practice,mechanisms,applicable people and recommended standard,etc.This article will make a comprehensive interpretation of the guidelines.

参考文献/References:

[1] 邵毅.国际干眼新共识(TFOSDEWS Ⅱ)解读[J].眼科新进展,2018,38(1):1-12.

SHAO Y.Interpretation of TFOS DEWS Ⅱ[J].Rec Adv Ophthalmol,2018,38(1):1-12.
[2] MIZOGUCHI S,IWANISHI H,ARITA R,SHIRAI K,SUMIOKA T,KOKADO M,et al.Ocular surface inflammation impairs structure and function of meibomian gland[J].Exp Eye Res,2017,163:78.
[3] WILLCOX M D P,PABLO A,GEORGIEV G A,HOLOPAINEN J M,JONES L W.TFOS DEWS II tear film report[J].Ocul Surf,2017,15(3):366-403.
[4] WOLFFSOHN J S,ARITA R,CHALMERS R,DJALILIAN A,CRAIG J P.TFOS DEWS II diagnostic methodology report[J].Ocul Surf,2017,15(3):539-574.
[5] BRON A J,PAIVA C S D,CHAUHAN S K,BONINI S,SULLIVAN D A.TFOS DEWS II pathophysiology report[J].Ocul Surf,2017,15(3):438-510.
[6] BUCHHOL Z P,STEEDS C S,STERN L S,WIEDERKEHR D P,DOYLE J J,KATZ L M,et al.Utility assessment to measure the impact of dry eye disease[J].Ocul Surf,2006,4(3):155-161.
[7] CHAN R,MICHELSON J B,BELMONT J B,MICHELSON P E.Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca[J].Arthrit Rheum,1984,27(4):459-461.
[8] THAN J,BALAL S,WAWRZYNSKI J,NESARATNAM N,SALEH G M,MOORE J,et al.Fingerprick autologous blood:a novel treatment for dry eye syndrome[J].Eye,2017,31:1655-1663.
[9] NOBLE B A.Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease[J].Br J Ophthalmol,2004,88(5):647-652.
[10] SONI N G,JENG B H.Blood-derived topical therapy for ocular surface diseases[J].Br J Ophthalmol,2016,100(1):22-27.
[11] AKPEK E K,LINDSLEY K B,ADYANTHAYA R S,SWAMY R,MCDONNELL P J.Treatment of Sjogren’s syndrome-associated dry eye:an evidence-based review[J].Ophthalmology,2011,118(7):1242-1252.
[12] AZARI A A,RAPUANO C J.Autologous serum eye drops for the treatment of ocular surface disease[J].Eye Contact Lens,2015,41(3):133-140.
[13] CIRALSKY J B,SIPPEL K C,GREGORY D G.Current ophthalmologic treatment strategies for acute and chronic Stevens-Johnson syndrome and toxic epidermal necrolysis[J].Curr Opin Ophthalmol,2013,24(4):321-328.
[14] CELEBI A R,ULUSOY C,MIRZA G E.The efficacy of autologous serum eye drops for severe dry eye syndrome:a randomized double-blind crossover study[J].Graefes Arch Clin Exp Ophthalmol,2014,252:619-626.
[15] HUSSAIN M,SHTEIN R M,SUGAR A,SOONG H K,WOODWARD M A,DELOSS K,et al.Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease[J].Cornea,2014,33(12):1245-1251.
[16] LIU Y,HIRAYAMA M,CUI X,CONNELL S,TSUBOTA K.Effectiveness of autologous serum eye drops combined with punctal plugs for the treatment of Sjogren syndrome-related dry eye[J].Cornea,2015,34(10):1214-1220.
[17] TAHMAZ V,GEHLSEN U,SAUERBIER L,HOLTICK U,ENGEL L,RADOJSKA S,et al.Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system:a retrospective cohort study[J].Br J Ophthalmol,2017,101(3):322-326.
[18] SCHULZE S D,SEKUNDO W,KROLL P.Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy[J].Am J Ophthalmol,2006,142(2):207-211.
[19] LEKHANONT K,JONGKHAJORNPONG P,CHOUBTUM L,CHUCKPAIWONG V.Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery[J].BioMed Res Internat,2013,2013:521315.
[20] GEERLING G,MACLENNAN S,HARTWIG D.Drops for ocular surface disorders[J].Br J Ophthalmol,2004,88:1467-1474.
[21] CHO Y K,HUANG W,KIM G Y,LIM B S.Comparison of autologous serum eye drops with different diluents[J].Curr Eye Res,2013,38(1):9-17.

相似文献/References:

[1]饶卓群 杨燕宁 袁静 曹瑾 满子惠.持续配戴软性角膜接触镜在治疗眼表疾病中的应用[J].眼科新进展,2013,33(10):000.
[2]王雯婕,陈剑,王园园,等.氧化应激与眼表疾病关系的研究进展[J].眼科新进展,2014,34(6):585.[doi:10.13389/j.cnki.rao.2014.0162]
[3]袁媛.干眼危险因素的研究[J].眼科新进展,2017,37(12):1173.[doi:10.13389/j.cnki.rao.2017.0296]
 YUAN Yuan.Risk factors for dry eye[J].Recent Advances in Ophthalmology,2017,37(2):1173.[doi:10.13389/j.cnki.rao.2017.0296]
[4]兰东怡,石文卿,邵毅.干眼与眼部神经病理性疼痛相关性进展[J].眼科新进展,2019,39(5):491.[doi:10.13389/j.cnki.rao.2019.0113]
 LAN Dong-Yi,SHI Wen-Qing,SHAO Yi.Progress in the correlation between dry eye and neuropathic pain[J].Recent Advances in Ophthalmology,2019,39(2):491.[doi:10.13389/j.cnki.rao.2019.0113]
[5]孙广莉,韩文杰,刘方,等.飞秒激光制瓣的准分子激光原位角膜磨镶术与全飞秒激光小切口角膜基质内透镜取出术对屈光不正患者眼表的影响[J].眼科新进展,2021,41(4):333.[doi:10.13389/j.cnki.rao.2021.0069]
 SUN Guangli,HAN Wenjie,LIU Fang,et al.Effects of femtosecond laser in situ keratomileusis and full femtosecond laser small incision corneal stromal lens removal refractive surgery on ocular surface in patients with ametropia[J].Recent Advances in Ophthalmology,2021,41(2):333.[doi:10.13389/j.cnki.rao.2021.0069]
[6]《眼表疾病常用非接触式影像学检查设备规范操作指南(0)》专家组,中国医药教育协会眼科影像与智能医疗分会,世界中医药学会联合会眼科专委会.眼表疾病常用非接触式影像学检查设备规范操作指南(2023)[J].眼科新进展,2023,43(6):421.[doi:10.13389/j.cnki.rao.2023.0085]
 Expert Workgroup of Standard Operating Guidelines for Non-Contact Imaging Equipment Commonly Used in Ocular Surface Diseases0,Ophthalmic Imaging and Intelligent Medicine Branch of China Medical Education Association,Ophthalmology Branch of World Federation of Chinese Medicine Societies.Standard operating guideline for non-contact imaging devices commonly used in ocular surface diseases (2023)[J].Recent Advances in Ophthalmology,2023,43(2):421.[doi:10.13389/j.cnki.rao.2023.0085]
[7]张子然,李柯然.角膜淋巴管生成的内源性调控因素及新生淋巴管相关眼表疾病研究进展[J].眼科新进展,2024,44(3):239.[doi:10.13389/j.cnki.rao.2024.0047]
 ZHANG Ziran,LI Keran.Research progress in the endogenous regulatory factors of corneal lymphangiogenesis and its related ocular surface diseases[J].Recent Advances in Ophthalmology,2024,44(2):239.[doi:10.13389/j.cnki.rao.2024.0047]

备注/Memo

备注/Memo:
国家自然科学基金资助(编号:81660158、81460092、81400372);江西省自然科学基金重大项目(编号:20161ACB21017);江西省青年科学基金(编号:20151-BAB215016、20161BAB215198);江西省重点研发项目(编号:20151-BBG70223、20181BBG70004);江西省教育厅重点项目(编号:GJJ160-020);江西省学位与研究生教育教学改革研究项目(编号:JXYJG-2018-013);江西省杰出青年人才计划(编号:S2019RCQNB0259)
更新日期/Last Update: 2020-02-05